OurPharma

Morphine Sulfate 1mg/mL in 0.9% NaCl 30mL, available in a 30mL PCA vial, pre-filled and ready-to-administer.

Our Pharma has a portfolio of sterile, ready-to-administer CII controlled substances made under rigorous cGMP-compliant conditions.

The page invites visitors to start a pharmaceutical manufacturing career at a 503B outsourcing facility.

OurPharma is a DEA and FDA-registered 503B outsourcing facility created for the need for compounded medications that are in short supply.

OurPharma has a portfolio of sterile, ready-to-administer CII controlled substances including cassettes, injectables & intravenous fluids.

OurPharma focuses on delivering compounded pharmaceuticals from a 503B outsourcing facility.

Our Pharma states that it protects privacy and secures the information it collects.

The terms of use apply to all services provided by Our Pharma and explain the agreement with the company.

Multi-Management Services Inc. acquires a 24,750-square-foot industrial building in southeast Fayetteville for $15 million. The sale reflects a per-square-foot price of $606. The property is managed as part of a portfolio affiliated with Little Rock-based health services.

Nov 2025Talk Business & PoliticsNews article

OurPharma LLC expands its licensed compounding pharmacy operations to 11 states, including Arkansas, and has pending applications in over 10 additional states to distribute custom pharmaceuticals nationwide. The company, based in Fayetteville, focuses on tailored drug formulations for patient-specific needs.

Sep 2021Arkansas Business — Business News, Real Estate, Law, ConstructionNews article

Arkansas-based **Pharmaco Northwest** (unnamed in article) begins producing **generic insulin** to lower prescription drug costs for families. The company aims to manufacture affordable medications locally in Northwest Arkansas, addressing high drug prices. This marks the state’s first generic drug production facility.

Jul 2018KOLR - OzarksFirst.comNews article

OurPharma is building Arkansas’ first generic drug manufacturing facility in Fayetteville. The company is establishing its production site in the city’s commercial district to enter the pharmaceutical market. Construction marks a milestone for Arkansas’ growing life sciences sector.

Jul 2018AMPNews article